Bayer Aktienges ADR (OP: BAYRY )

6.800 +0.030 (+0.44%)

Streaming Delayed Price Updated: 3:59 PM EDT, Nov 1, 2024 Add to My Watchlist

Price and Volume

Volume	2,292,761
Open	6.810
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	6.770
Today's Range	6.750 - 6.870
52wk Range	6.740 - 11.34
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bayer Seeks European Approval For Its Menopause Drug

October 15, 2024

Bayer has submitted an MAA to the EMA for elinzanetant, targeting moderate to severe vasomotor symptoms linked to menopause. Phase 3 trials showed significant reductions in VMS and improved quality of...

Via Benzinga

Bayer Seeks European Approval For Third Indication For Cancer Drug Darolutamide

October 14, 2024

Bayer is seeking EMA approval for darolutamide in metastatic hormone-sensitive prostate cancer, building on promising Phase III ARANOTE trial results. The treatment significantly lowers progression...

Via Benzinga

Performance

YTD	-27.51%	-27.51%
1 Month	-17.58%	-17.58%
3 Month	-8.85%	-8.85%
6 Month	-10.64%	-10.64%
1 Year	-39.69%	-39.69%

More News

Week In Review: Zenas Raises $259 Million In IPO

September 28, 2024

Via Talk Markets

Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea

September 23, 2024

Via Investor's Business Daily

“Signing Day Sports, Inc. (NYSE American: SGN) Soars in Pre-Market on Acquisition News – see more penny stocks inside….”

September 19, 2024

Via AB Newswire

Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study

September 16, 2024

Via Benzinga

Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer

September 10, 2024

Via Benzinga

Why Is BridgeBio Pharma Stock Trading Higher On Friday?

August 30, 2024

Via Benzinga

BAYRY Stock Earnings: Bayer Meets EPS, Beats Revenue for Q2 2024

August 06, 2024

Via InvestorPlace

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer

July 25, 2024

Via Benzinga

ScottsMiracle-Gro Stock Blooms After Investor Day Optimism

July 23, 2024

Via MarketBeat

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs

July 08, 2024

Via InvestorPlace

3 Small-Cap Stocks With Explosive 2X Growth Potential

July 08, 2024

Via InvestorPlace

Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M

June 05, 2024

Via Benzinga

Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership

June 01, 2024

Via Talk Markets

European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?

May 27, 2024

Via Benzinga

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February

May 24, 2024

Via Benzinga

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

May 17, 2024

Via Benzinga

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

May 16, 2024

Via Benzinga

BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024

May 14, 2024

Via InvestorPlace

From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch

May 10, 2024

Via Benzinga

Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned

May 02, 2024

Via Benzinga

Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'

April 10, 2024

Via Benzinga

Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists

April 09, 2024

Via Benzinga

Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds

April 05, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.